Cantabio Pharmaceuticals Inc. | Finanzwire

Basculer en Français

10184	Companies
209565	Keywords
139697	Articles
111103	Press releases

Headlines Articles Press releases Cantabio Pharmaceuticals Inc.

Home
Companies
Cantabio Pharmaceuticals Inc.

PRESS RELEASE

published on 02/06/2024 at 16:00, 2 years 2 months ago

Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. receives major grant from MJFF for the development of DJ-1 replacement therapy aimed at treating Parkinson's disease by increasing DJ-1 levels in patients and preventing disease progression

Precision Medicine Cantabio Pharmaceuticals MJFF Grant DJ-1 Replacement Therapy Parkinson's Disease

Accesswire

Published on 04/09/2026 at 19:15, 1 hour 9 minutes ago

Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 24 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 44 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 24 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 6 hours 54 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

View all ACCESSWIRE

EQS Group

Published on 04/09/2026 at 20:03, 20 minutes ago

Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:15, 2 hours 8 minutes ago

REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:59, 4 hours 24 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 4 hours 27 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:40, 4 hours 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Les Echos

Published on 04/09/2026 at 18:35, 1 hour 49 minutes ago

Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:35, 2 hours 49 minutes ago

SUEZ - FY 2025
Published on 04/09/2026 at 15:57, 4 hours 26 minutes ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 13 hours 24 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 2 hours ago

Publication of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE